ChartRow logo
GMAB
$39.07+1.48%
as of close, Oct 20, 2026
☾ AH $39.07 +1.48%
Genmab A/S ADSStock · Healthcare
PeersABVXSPYQQQNVDAAAPLMSFT
Share this page

Genmab A/S ADS trailing returns

Genmab A/S ADS's 10-year return is +8.7% a year (CAGR) (+130.1% cumulative). How Genmab A/S ADS (GMAB) has performed over the last day, week, month and year, over 5 and 10 years, and since inception, through October 20, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-20. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day+1.5%+0.0%+1.5%—
5 days+6.8%+0.0%+6.8%-2.2%Oct 16
1 month+12.5%+0.0%+12.5%-6.3%Oct 8
YTD+26.9%+0.0%+26.9%-32.5%Jun 2
1 year+27.9%+0.0%+27.9%-32.5%Jun 2026
5 years-3.1%+0.0%-3.1%-14.8%-61.8%Apr 2025
10 years+8.7%+0.0%+8.7%+130.1%-63.1%Apr 2025
Since inception (2009)+14.4%+0.0%+14.4%+935.8%-84.2%Aug 2011

Growth of GMAB#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years-3.1%/year · -14.8%
  • 10 years+8.7%/year · +130.1%
  • Since inception (2009)+14.4%/year · +935.8%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-20). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in GMAB's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Genmab A/S ADS's 10-year return?
Over the last 10 years, Genmab A/S ADS (GMAB) returned about +8.7% a year annualized (+130.1% cumulative total return).
What is Genmab A/S ADS's return since inception?
Since 2009, Genmab A/S ADS (GMAB) has compounded at about +14.4% a year — +935.8% in total.

More on Genmab A/S ADS